Ipsen launches Decapeptyl LP 22.5 mg 6-month formulation in France
Friday, February 05, 2010 09:00 IST Paris
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs
